Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • altodor
    Member
    • Nov 2009
    • 12

    #1

    Cuffdiff and zero FPKM values give enormous log ratio

    Hi all,
    I'm new to RNA seq and I'm working with TopHat - Cufflinks - Cuffcompare - Cuffdiff pipeline.
    I use Cufflinks without annotation and then Cuffcompare for two samples with annotation. I put the results of Cuffcompare (transcripts.combined.gtf) to Cuffdiff as input. Is this the right way?

    I have results from cuffdiff for differential expression testing. As a result for DE testing it provides the following measure: ln(FPKMx/FPKVy) for ratio for the gene between two samples X and Y. If for gene A in sample X FPKMx = 2 and for the sample Y FPKMy=0, then the ratio is like 1,79 E306, so enormously big
    How do you deal with it?

    Any ideas are very welcome!
  • dahlo
    Junior Member
    • Sep 2010
    • 8

    #2
    Hello

    Regarding the huge ratios, i think they are hard to avoid. There is no other way to handle the scenarios where you have a gene that is switched on/off, that i know of.

    If you were to plot your ratio values, you would likely see most of them around 0 - a couple of thousand perhaps, and some scattered outliers with ridiculous high values. You can then set a suitable cutoff and say that all genes with a ratio higher than X (say 1e10 or 1e20) are genes that have been turned off or on. It is pointless to sort them with respect to their ratio size, since they all should have Inf.

    Computers don't like to divide by 0, so a small number (like 1e-500 or so) has been added to the FPKMy in the division to keep the program from crashing, since many programming languages can't handle infinite numbers.

    Cheers
    Dahlo

    Comment

    • altodor
      Member
      • Nov 2009
      • 12

      #3
      Thank you!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...